Mahoney, Meghan

Medical Oncology

Medical Oncologist, Assistant Professor

Biography

Dr. Meghan Mahoney is a medical oncologist and Assistant Professor at the Arthur Child Comprehensive Cancer Centre and the University of Calgary, where she specializes in genitourinary and cutaneous malignancies. She completed her Internal Medicine residency and Medical Oncology training at Memorial University of Newfoundland, followed by a fellowship in genitourinary and cutaneous oncology at Princess Margaret Cancer Centre in Toronto, completed in September 2024.

Dr. Mahoney’s research interests include adoptive cellular therapy, predictive biomarkers, clinical trial reform, and equitable access to care. She joined the Arthur Child Comprehensive Cancer Centre in 2024 and is building her career as a clinician scientist in Calgary.

Area of Focus

Cutaneous and Genitourinary Malignancies

Summary of Research

Dr. Mahoney is a medical oncologist with a focused and growing publication record in oncology outcomes, population-based research, and clinical innovation. She is first author on multiple peer-reviewed publications, including a recent study in the Journal of the American Academy of Dermatology on younger age at melanoma diagnosis and indoor tanning behaviors. Her prior work includes a population-based analysis of young women with breast cancer in Newfoundland and Labrador, contributions to the Eastern Canadian Gastrointestinal Cancer Consensus Conference, and a publication on clinical trial reform in the post-COVID era. She also has ongoing first-author work evaluating long-term outcomes of neoadjuvant chemotherapy prior to bladder-sparing chemoradiotherapy in muscle-invasive bladder cancer.

Area Of Focus

Cutaneous and Genitourinary Malignancies

Summary Of Research

Dr. Mahoney is a medical oncologist with a focused and growing publication record in oncology outcomes, population-based research, and clinical innovation. She is first author on multiple peer-reviewed publications, including a recent study in the Journal of the American Academy of Dermatology on younger age at melanoma diagnosis and indoor tanning behaviors. Her prior work includes a population-based analysis of young women with breast cancer in Newfoundland and Labrador, contributions to the Eastern Canadian Gastrointestinal Cancer Consensus Conference, and a publication on clinical trial reform in the post-COVID era. She also has ongoing first-author work evaluating long-term outcomes of neoadjuvant chemotherapy prior to bladder-sparing chemoradiotherapy in muscle-invasive bladder cancer.